Skip to main content
. 2018 Jun 15;45(8):951–962. doi: 10.1111/1346-8138.14497

Figure 5.

Figure 5

Patient preference assessment scores for (a) ease of application, (b) comfort, (c) satisfaction with treatment, (d) comparison with prior treatments and (e) willingness to continue using treatment (ITT population). ADA, adapalene; BPO, benzoyl peroxide; CLNP, clindamycin phosphate; ITT, intent‐to‐treat.